Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Acute Pharyngitis

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Parent Experiences Accessing Inpatient Clinical Notes on a Pediatric Oncology Service.

Hospital pediatrics·2026

Same author

Epigenetic consequences of toxic stress in preterm infants and their mothers: protocol for the premature infants, moms, and the social determinants of health-an epigenetic investigation study.

Frontiers in pediatrics·2026

Same author

Why Have All the Doctors Gone? Insights Into Early Clinical Departure Among Physicians in the United States: A National Survey.

The Permanente journal·2026

Same author

Weak selection and stochastic processes limit the emergence of antigenic variants during household transmission of influenza A viruses.

PLoS pathogens·2026

Same author

Physician Intent to Reduce Hours and Intent to Leave Organizations.

JAMA network open·2026

Same author

Nasal steroids, irrigation, oral antibiotics, and subgroup targeting for effective management of acute sinusitis (NOSES): Protocol for a comparative effectiveness randomized controlled trial.

PloS one·2026

Same journal

Correction to I.M. Matters News: Sleep medicine for seniors.

Annals of internal medicine·2026

Same journal

Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone : A Target Trial Emulation.

Annals of internal medicine·2026

Same journal

Leveraging Real-World Evidence to Inform Regulatory, Clinical, and Coverage Decisions Related to Glucagon-Like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Annals of internal medicine·2026

Same journal

Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Annals of internal medicine·2026

Same journal

Weekly and Biweekly Treatment With Bofanglutide Versus Semaglutide in Chinese Patients With Type 2 Diabetes : A Phase 2b Randomized Clinical Trial.

Annals of internal medicine·2026

Same journal

Grappling with GLP-1 prescribing.

Annals of internal medicine·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 4, 2026

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Echinacea for treating the common cold: a randomized trial.

Bruce Barrett¹, Roger Brown, Dave Rakel

¹Department of Family Medicine, University of Wisconsin, Madison, Wisconsin 53715, USA.

Annals of Internal Medicine

|December 22, 2010

Summary

This summary is machine-generated.

Echinacea did not significantly reduce common cold duration or severity in this trial. The study found no substantial benefit of this echinacea dose for treating cold symptoms.

More Related Videos

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

Related Experiment Videos

Last Updated: May 4, 2026

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

Area of Science:

Herbal medicine research
Clinical trial methodology
Common cold treatment efficacy

Background:

Echinacea is a popular herbal remedy widely used for common cold symptom relief.
Scientific evidence supporting echinacea's efficacy for the common cold remains inconclusive.
This study aimed to rigorously evaluate echinacea's therapeutic potential.

Purpose of the Study:

To assess the potential benefits of echinacea in treating the common cold.
To determine if echinacea impacts cold severity and duration.
To investigate the effect of echinacea on specific inflammatory markers.

Main Methods:

A randomized, controlled trial involving 719 patients with new-onset common cold.
Four parallel groups: no pills, blinded placebo, blinded echinacea, and unblinded echinacea.
Primary outcome: global symptom severity assessed via the Wisconsin Upper Respiratory Symptom Survey. Secondary outcomes: interleukin-8 levels and neutrophil counts.

Main Results:

No statistically significant difference in illness duration or severity between echinacea and placebo groups.
A trend towards benefit for echinacea in blinded groups (P=0.089 for severity, P=0.075 for duration) was observed but did not reach statistical significance.
Interleukin-8 levels and neutrophil counts showed no significant changes across groups.

Conclusions:

The study did not find statistically significant evidence that echinacea, at the tested dose and formulation, substantively alters the course of the common cold.
Higher-than-expected variability in patient responses limited the study's power to detect small benefits.
Results do not support the use of this echinacea formulation for clinically meaningful common cold treatment.